News & Analysis on Clinical Trial Services & Contract Research And Development
People on the Move
By Melissa Fassbender
- Last updated on
Peregrine Pharmaceuticals recently announced its transition to a contract development and manufacturing organization (CDMO). As part of this, Roger Lias was brought on to lead Avid Bioservices, which will remain the company’s sole focus after the Peregrine label is abandoned.
“I am delighted to be joining the team at Avid Bioservices as the company is transitioning to a pure play contract development and manufacturing organization,” Lias told us.
“I believe that Avid Bioservices is exceptionally well positioned to assist clients in bringing important biologic drugs rapidly and cost-effectively to patients.”